Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.
about
Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental designSplanchnic-aortic inflammatory axis in experimental portal hypertensionExploring host-microbiota interactions in animal models and humansEndometriosis, angiogenesis and tissue factorEnteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications[Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases].Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota.Impact of stressor exposure on the interplay between commensal microbiota and host inflammationImmune and genetic gardening of the intestinal microbiome.Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences.Gut microbial colonization orchestrates TLR2 expression, signaling and epithelial proliferation in the small intestinal mucosaNonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?Role of the protein C receptor in cancer progression.The gut microbiome as novel cardio-metabolic target: the time has come!Angiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy.Analysis of gene-environment interactions in postnatal development of the mammalian intestine.TLR5 expression in the small intestine depends on the adaptors MyD88 and TRIF, but is independent of the enteric microbiota.Intestinal microbiota modulates gluten-induced immunopathology in humanized mice.Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.Accounting for reciprocal host-microbiome interactions in experimental science.Quantitative assessment of the impact of the gut microbiota on lysine epsilon-acetylation of host proteins using gnotobiotic micePreterm infant gut microbiota affects intestinal epithelial development in a humanized microbiome gnotobiotic mouse model.Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.Antibiotic-Induced Changes in the Intestinal Microbiota and Disease.Relationship between the microbiota in different sections of the gastrointestinal tract, and the body weight of broiler chickensObesity and the gut microbiome: Striving for causality.Anaerobic choline metabolism in microcompartments promotes growth and swarming of Proteus mirabilisAltered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture.Comparison of gene expression profiles and related pathways in chronic thromboembolic pulmonary hypertension.From meta-omics to causality: experimental models for human microbiome research.Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism.Regulation of metabolism: a cross talk between gut microbiota and its human host.Protein disulfide-isomerase - a trigger of tissue factor-dependent thrombosis.Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligands.Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals.High-resolution 3D analysis of mouse small-intestinal stroma.Human Gut Microbiota: Toward an Ecology of Disease.PTEN plays an important role in thrombin-mediated lung cancer cell functions.IL-18 is not therapeutic for neovascular age-related macular degeneration.Keystone microbiome meeting 2012: a mountain top experience.
P2860
Q26795715-57D938D2-77BF-43A1-867E-6D9233A5AC3AQ26995820-0F8986B6-E76B-41C5-BA02-694DF0F73800Q26999643-5F846864-2CC4-45C8-B002-BE29069E9C87Q27013803-AC8F1B41-A253-4790-A534-885D6926068DQ27027602-39FBFFED-B157-458E-96B7-844A51FF0788Q30353345-9DFA9F2B-8C02-4B2E-B786-8856A6B9B113Q33927170-84D01F06-3618-45B8-91B7-6733390C8EE7Q34129398-5E94A064-6C20-4B15-AF9C-B181510E33CCQ34143465-C463B204-B175-4B1F-933E-3CA9B8A27A54Q34324267-AEEBD1C0-03DF-4E05-A88D-2ECD992D2BDDQ34514746-AB494FDB-EA5E-4F16-9C11-87A875BEF165Q34641213-18461254-B8C4-46CA-B809-4F413F5BDC15Q34731385-D2A5EA71-73BC-4B47-8413-090AEEBB76D1Q35038619-83773D50-748A-4835-A986-1BEE76EF92C3Q35075339-87692E3F-00DF-47C3-B9C3-5870615D5FB9Q35128962-B373FB80-7CEE-4095-99B6-30B80317E0ACQ35617800-A04B335E-F78D-4A8D-B583-E6137C854545Q35803031-5F8056A0-C4D1-418D-95ED-C9A0910B5637Q35819570-33260114-C082-4840-894F-C42D00B53E8DQ36045875-A696D954-8FA9-453D-AFAE-BEBEAFADEC71Q36094206-29F70C78-CC96-471D-A752-BC9ADABB6A7CQ36095493-5FBAFD09-0788-4732-9297-E40750086125Q36322931-217FA512-AAAC-4CE7-BE7C-58823D185C2AQ36948447-063722C1-2567-48DE-9AC7-547192C1AAD8Q37053312-C24C3B18-4628-4B57-AB67-79D054E8BDF5Q37133415-11636110-A0E4-41FE-97D0-4B1A60E31691Q37261624-5531464F-FBC7-42DC-A42E-C165D6B7DC0DQ37458589-E27E764B-8B5E-441E-A9B4-CCF6F08CAFE4Q37496096-C68FDB2E-C4DD-476E-8BFE-F9F71901077AQ37677334-5087C61A-5564-4927-BDC8-20485442A28CQ37727703-071632BF-6D56-4821-A5AF-653D89D9A9F1Q38048563-F85DAEDF-7A9D-44DA-A148-2717DD757F33Q39106518-B7B111E5-ED1E-44DD-86AE-5D52D1660AC4Q39228077-3DE1C89F-4E1C-45BE-8C93-5A66718AB7F1Q39263514-8DB521CF-5EAC-496E-8325-BDC2C244CE65Q40563361-02339856-BB6E-455D-8F7E-B829DFE54788Q41024163-01D04355-F073-449F-A08D-AF581632321BQ41941690-113629B9-2458-4D82-A5B6-5431022F8D57Q43009110-DF21C448-EF53-40E6-9BF0-2D4AED6F0612Q45969815-CAFD9B5C-2A7A-4B86-BC6D-D1FDF35762B0
P2860
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.
@en
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.
@nl
type
label
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.
@en
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.
@nl
prefLabel
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.
@en
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.
@nl
P2093
P2860
P356
P1433
P1476
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.
@en
P2093
Christoph Reinhardt
Florence Schaffner
Gunnel Ostergren-Lundén
Lars C Petersen
Mattias Bergentall
Thomas U Greiner
Wolfram Ruf
P2860
P2888
P304
P356
10.1038/NATURE10893
P407
P577
2012-03-11T00:00:00Z
P5875
P6179
1048239250